Karen Firestone - Net Worth and Insider Trading
Karen Firestone Net Worth
The estimated net worth of Karen Firestone is at least $9,150 dollars as of 2024-05-18. Karen Firestone is the Director of Amylyx Pharmaceuticals Inc and owns about 5,000 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $9,150. Details can be seen in Karen Firestone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karen Firestone has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).
Transaction Summary of Karen Firestone
Karen Firestone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Firestone owns 1 companies in total, including Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of Karen Firestone’s form 4 insider trades.
Insider Ownership Summary of Karen Firestone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2023-12-15 | director |
Karen Firestone Latest Holdings Summary
Karen Firestone currently owns a total of 1 stock. Karen Firestone owns 5,000 shares of Amylyx Pharmaceuticals Inc (AMLX) as of December 15, 2023, with a value of $9,150.
Latest Holdings of Karen Firestone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals Inc | 2023-12-15 | 5,000 | 1.83 | 9,150 |
Holding Weightings of Karen Firestone
Karen Firestone Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Firestone has made a total of 2 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the acquisition of 4,000 shares on December 15, 2023, which cost Karen Firestone around $59,880.
Insider Trading History of Karen Firestone
- 1
Karen Firestone Trading Performance
GuruFocus tracks the stock performance after each of Karen Firestone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen Firestone is -51.41%. GuruFocus also compares Karen Firestone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen Firestone within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen Firestone's insider trading performs compared to the benchmark.
Performance of Karen Firestone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.24 | | | | | |
| Relative Return to S&P 500(%) | -0.69 | | | | | |
Karen Firestone Ownership Network
Karen Firestone Owned Company Details
What does Amylyx Pharmaceuticals Inc do?
Who are the key executives at Amylyx Pharmaceuticals Inc?
Karen Firestone is the director of Amylyx Pharmaceuticals Inc. Other key executives at Amylyx Pharmaceuticals Inc include Chief Legal Officer Gina Mazzariello , director & Co-Chief Executive Officer Joshua B Cohen , and director & Co-Chief Executive Officer Justin B. Klee .
Amylyx Pharmaceuticals Inc (AMLX) Insider Trades Summary
Over the past 18 months, Karen Firestone made 2 insider transaction in Amylyx Pharmaceuticals Inc (AMLX) with a net purchase of 5,000. Other recent insider transactions involving Amylyx Pharmaceuticals Inc (AMLX) include a net sale of 583,296 shares made by Morningside Venture Investments Ltd , a net sale of 175,644 shares made by Patrick D Yeramian , and a net sale of 104,666 shares made by James M Frates .
In summary, during the past 3 months, insiders sold 24,895 shares of Amylyx Pharmaceuticals Inc (AMLX) in total and bought 5,000 shares, with a net sale of 19,895 shares. During the past 18 months, 1,157,480 shares of Amylyx Pharmaceuticals Inc (AMLX) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 1,147,480 shares.
Amylyx Pharmaceuticals Inc (AMLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amylyx Pharmaceuticals Inc Insider Transactions
Karen Firestone Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Firestone. You might contact Karen Firestone via mailing address: C/o Amylyx Pharmaceuticals, Inc., 43 Thorndike St., Cambridge Ma 02141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
